XOMA Royalty (XOMA) Treasury Shares (2011 - 2026)
XOMA Royalty (XOMA) reported Treasury Shares of $841442.0 for Q1 2026, up 5444.92% on a YoY basis from $15175.0 in Q1 2025, and up 2718.43% sequentially from $29855.0 in Q4 2025.
XOMA Royalty (XOMA) Treasury Shares (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 12 years of Treasury Shares data on file, last reported at $841442.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 5444.92% year-over-year to $841442.0; the trailing twelve-month figure through Mar 2026 stood at $841442.0 (up 5444.92% YoY), and the FY2025 full-year result was $379907.0, up 2403.51% from the prior year.
- Treasury Shares advanced to $841442.0 in Q1 2026, from $29855.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $841442.0 in Q1 2026 to a low of $5000.0 in Q4 2023.
- A 4-year average of $335480.4 and a median of $430400.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares slumped 97.9% in 2025 and surged 5444.92% in 2026, its largest moves.
- Tracing XOMA's Treasury Shares over 4 years: stood at $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then soared by 497.1% to $29855.0 in 2025, then surged by 2718.43% to $841442.0 in 2026.
- Business Quant data shows XOMA's Treasury Shares at $841442.0 in Q1 2026, $29855.0 in Q4 2025, and $460637.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 841,442.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 841,442.00 |
| Mar 31, 2026 | 841,442.00 |
| Dec 31, 2025 | 29,855.00 |
| Dec 31, 2025 | 29,855.00 |
| Jun 30, 2025 | 460,637.00 |
| Jun 30, 2025 | 460,637.00 |
| Mar 31, 2025 | 15,175.00 |
| Mar 31, 2025 | 15,175.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 733,600.00 |
| Sep 30, 2024 | 733,600.00 |
| Jun 30, 2024 | 15,175.00 |
| Jun 30, 2024 | 15,175.00 |
| Mar 31, 2024 | 723,600.00 |
| Mar 31, 2024 | 723,600.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 430,400.00 |
| Sep 30, 2023 | 430,400.00 |